{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T18:39:55Z","timestamp":1788719995747,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.ghir.2016.09.001","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T18:07:33Z","timestamp":1473876453000},"page":"2-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["A summary of the influence of exogenous estrogen administration across the lifespan on the GH\/IGF-1 axis and implications for bone health"],"prefix":"10.1016","volume":"32","author":[{"given":"Emily A.","family":"Southmayd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jane","family":"De Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2016.09.001_bb0005","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ghir.2016.09.001_bb0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.2007-0036","article-title":"Growth hormone, insulin-like growth factors, and the skeleton","volume":"29","author":"Giustina","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2016.09.001_bb0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1677\/JOE-09-0431","article-title":"The GH\/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis","volume":"205","author":"Perrini","year":"2010","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ghir.2016.09.001_bb0020","first-page":"657","article-title":"Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism","volume":"52","author":"Zofkova","year":"2003","journal-title":"Physiological research\/Academia Scientiarum Bohemoslovaca"},{"key":"10.1016\/j.ghir.2016.09.001_bb0025","series-title":"Principles of Bone Biology","article-title":"ScienceDirect (online service)","author":"Bilezikian","year":"2008"},{"key":"10.1016\/j.ghir.2016.09.001_bb0030","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/bonekey.2013.171","article-title":"IGF-1 regulation of key signaling pathways in bone","volume":"2","author":"Guntur","year":"2013","journal-title":"BoneKEy reports"},{"key":"10.1016\/j.ghir.2016.09.001_bb0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/er.2005-0006","article-title":"Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition","volume":"27","author":"Veldhuis","year":"2006","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2016.09.001_bb0040","first-page":"1","article-title":"Use of contraception in the United States: 1982\u20132008","volume":"23","author":"Mosher","year":"2010","journal-title":"Vital Health Stat."},{"key":"10.1016\/j.ghir.2016.09.001_bb0045","series-title":"National Health Statistics Reports, No 62","article-title":"Contraceptive methods women have ever used: United States, 1982\u20132010","author":"Daniels","year":"2013"},{"key":"10.1016\/j.ghir.2016.09.001_bb0050","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jpag.2009.11.001","article-title":"Low-dose oral contraceptives in adolescents: how low can you go?","volume":"23","author":"Agostino","year":"2010","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"10.1016\/j.ghir.2016.09.001_bb0055","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1043-2760(00)00336-2","article-title":"Acquisition of optimal bone mass in childhood and adolescence","volume":"12","author":"Bachrach","year":"2001","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0060","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1001\/jama.1992.03490170075028","article-title":"Bone gain in young adult women","volume":"268","author":"Recker","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.ghir.2016.09.001_bb0065","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s001980070020","article-title":"Peak bone mass","volume":"11","author":"Heaney","year":"2000","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ghir.2016.09.001_bb0070","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrendo.2015.89","article-title":"Skeletal changes through the lifespan\u2014from growth to senescence","volume":"11","author":"Farr","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ghir.2016.09.001_bb0075","first-page":"1060","article-title":"Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16years of age at the levels of lumbar spine and femoral neck in female subjects","volume":"75","author":"Theintz","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0080","first-page":"179","article-title":"Effects of contraceptive use on bone biochemical markers in young women","volume":"86","author":"Ott","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.contraception.2007.10.007","article-title":"Short-term response of bone turnover to low-dose oral contraceptives in exercising women with hypothalamic amenorrhea","volume":"77","author":"Vescovi","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.ghir.2016.09.001_bb0090","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/8756-3282(95)00075-O","article-title":"Decreased bone turnover in oral contraceptive users","volume":"16","author":"Garnero","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.ghir.2016.09.001_bb0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.contraception.2004.04.004","article-title":"Short-term variations in bone remodeling markers of an oral contraception formulation containing 3mg of drospirenone plus 30microg of ethinyl estradiol: observational study in young postadolescent women","volume":"70","author":"Paoletti","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.ghir.2016.09.001_bb0100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.contraception.2006.06.005","article-title":"Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13cycles","volume":"74","author":"Hartard","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.ghir.2016.09.001_bb0105","doi-asserted-by":"crossref","first-page":"E1380","DOI":"10.1210\/jc.2010-3027","article-title":"Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuation","volume":"96","author":"Scholes","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0110","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.contraception.2012.04.009","article-title":"Hormonal contraception and bone metabolism: a systematic review","volume":"86","author":"Nappi","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.ghir.2016.09.001_bb0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/8756-3282(93)90254-8","article-title":"Oral contraceptive pill use and fractures in women: a prospective study","volume":"14","author":"Cooper","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.ghir.2016.09.001_bb0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0010-7824(98)00026-2","article-title":"Oral contraception and other factors in relation to hospital referral for fracture. Findings in a large cohort study","volume":"57","author":"Vessey","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.ghir.2016.09.001_bb0125","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000095523","article-title":"The role of insulin-like growth factor binding proteins","volume":"83","author":"Holly","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ghir.2016.09.001_bb0130","first-page":"699","article-title":"IGF-I\/IGFBP system: metabolism outline and physical exercise","volume":"35","author":"Gatti","year":"2012","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.ghir.2016.09.001_bb0135","first-page":"608","article-title":"Diminished function of the somatotropic axis in older reproductive-aged women","volume":"80","author":"Wilshire","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.steroids.2014.12.010","article-title":"Estrogen and bone health in men and women","volume":"99","author":"Cauley","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.ghir.2016.09.001_bb0145","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/13697137.2013.795683","article-title":"Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health","volume":"16","author":"de Villiers","year":"2013","journal-title":"Climacteric"},{"key":"10.1016\/j.ghir.2016.09.001_bb0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.6118\/jmm.2014.20.3.111","article-title":"Effect of transdermal estrogen therapy on bone mineral density in postmenopausal Korean women","volume":"20","author":"Kim","year":"2014","journal-title":"Journal of Menopausal Medicine"},{"key":"10.1016\/j.ghir.2016.09.001_bb0155","doi-asserted-by":"crossref","first-page":"B117","DOI":"10.1093\/gerona\/53A.2.B117","article-title":"Growth hormone in postmenopausal women after long-term oral estrogen replacement therapy","volume":"53","author":"Moe","year":"1998","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.ghir.2016.09.001_bb0160","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1359\/jbmr.060312","article-title":"Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial","volume":"21","author":"Jackson","year":"2006","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.ghir.2016.09.001_bb0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/13697137.2012.659975","article-title":"The WHI: the effect of hormone replacement therapy on fracture prevention","volume":"15","author":"de Villiers","year":"2012","journal-title":"Climacteric"},{"key":"10.1016\/j.ghir.2016.09.001_bb0170","first-page":"289","article-title":"Anabolic effect of estrogen replacement on bone in postmenopausal women with osteoporosis: histomorphometric evidence in a longitudinal study","volume":"86","author":"Khastgir","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-117-1-1","article-title":"Treatment of postmenopausal osteoporosis with transdermal estrogen","volume":"117","author":"Lufkin","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ghir.2016.09.001_bb0180","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1210\/jcem-63-2-424","article-title":"Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement","volume":"63","author":"Dawson-Hughes","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0185","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0378-5122(88)90094-1","article-title":"Growth hormone and somatomedin C during post-menopausal replacement therapy with oestrogen alone and in combination with an antioestrogen","volume":"9","author":"Frohlander","year":"1988","journal-title":"Maturitas"},{"key":"10.1016\/j.ghir.2016.09.001_bb0190","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1210\/jcem-72-2-374","article-title":"Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women","volume":"72","author":"Weissberger","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0195","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/09513599309152509","article-title":"Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels","volume":"7","author":"Campagnoli","year":"1993","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.ghir.2016.09.001_bb0200","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1067\/mob.2000.106994","article-title":"Progestins abrogate estrogen-induced changes in the insulin-like growth factor axis","volume":"183","author":"Heald","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ghir.2016.09.001_bb0205","doi-asserted-by":"crossref","first-page":"E1158","DOI":"10.1152\/ajpendo.00054.2011","article-title":"Complex regulation of GH autofeedback under dual-peptide drive: studies under a pharmacological GH and sex steroid clamp","volume":"300","author":"Veldhuis","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0210","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2265.1993.tb02410.x","article-title":"Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women","volume":"39","author":"Kelly","year":"1993","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2016.09.001_bb0215","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1530\/eje.1.02037","article-title":"GH responsiveness varies during the menstrual cycle","volume":"153","author":"Gleeson","year":"2005","journal-title":"European journal of endocrinology\/European Federation of Endocrine Societies"},{"key":"10.1016\/j.ghir.2016.09.001_bb0220","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1055\/s-2007-1001671","article-title":"The insulin-like growth factor I generation test: resistance to growth hormone with aging and estrogen replacement therapy","volume":"26","author":"Lieberman","year":"1994","journal-title":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme"},{"key":"10.1016\/j.ghir.2016.09.001_bb0225","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3109\/10408444.2014.930813","article-title":"Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps","volume":"44","author":"Mattison","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.ghir.2016.09.001_bb0230","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/jcem-62-3-536","article-title":"Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration","volume":"62","author":"De Lignieres","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0235","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1210\/jcem-72-1-172","article-title":"Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages","volume":"72","author":"Bellantoni","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0240","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-2007-1000814","article-title":"Lack of effect of transdermal estrogen on the growth hormone-insulin-like growth factor axis","volume":"26","author":"Dall'Aglio","year":"1994","journal-title":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme"},{"key":"10.1016\/j.ghir.2016.09.001_bb0245","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/BF03348801","article-title":"Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women","volume":"15","author":"Slowinska-Srzednicka","year":"1992","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.ghir.2016.09.001_bb0250","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/09513599809015598","article-title":"Insulin-like growth factor I (IGF-I) serum level modifications during transdermal estradiol treatment in postmenopausal women: a possible bimodal effect depending on basal IGF-I values","volume":"12","author":"Campagnoli","year":"1998","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.ghir.2016.09.001_bb0255","first-page":"2250","article-title":"Both oral and transdermal estrogen increase growth hormone release in postmenopausal women\u2014a clinical research center study","volume":"81","author":"Friend","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0260","first-page":"2848","article-title":"Effects of oral versus transdermal estrogen on the growth hormone\/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study","volume":"81","author":"Bellantoni","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0265","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1172\/JCI2773","article-title":"The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women","volume":"102","author":"O'Sullivan","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2016.09.001_bb0270","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymeth.2015.04.029","article-title":"Clinical assays for quantitation of insulin-like-growth-factor-1 (IGF1)","volume":"81","author":"Ketha","year":"2015","journal-title":"Methods"},{"key":"10.1016\/j.ghir.2016.09.001_bb0275","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/jbmr.5650070711","article-title":"Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism","volume":"7","author":"Ho","year":"1992","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.ghir.2016.09.001_bb0280","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1365-2265.1996.8610870.x","article-title":"Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study","volume":"45","author":"Helle","year":"1996","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2016.09.001_bb0285","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1046\/j.1365-2265.2003.01907.x","article-title":"Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women","volume":"59","author":"Nugent","year":"2003","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2016.09.001_bb0290","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0378-5122(94)90038-8","article-title":"Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary report","volume":"19","author":"Campagnoli","year":"1994","journal-title":"Mlaturitas"},{"key":"10.1016\/j.ghir.2016.09.001_bb0295","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","article-title":"Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts","volume":"130","author":"Nakamura","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ghir.2016.09.001_bb0300","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJM198411153112002","article-title":"Relative contributions of aging and estrogen deficiency to postmenopausal bone loss","volume":"311","author":"Richelson","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2016.09.001_bb0305","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1210\/jcem-25-11-1470","article-title":"Effects of estrogen and sex difference on secretion of human growth hormone","volume":"25","author":"Frantz","year":"1965","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0310","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1210\/jcem-33-6-896","article-title":"Studies of the sex based variation of human growth hormone secretion","volume":"33","author":"Merimee","year":"1971","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0315","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1210\/jcem-41-3-431","article-title":"Pattern of plasma ACTH, hGH, and cortisol during menstrual cycle","volume":"41","author":"Genazzani","year":"1975","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0320","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2265.1992.tb02270.x","article-title":"Pulsatile growth hormone release in normal women during the menstrual cycle","volume":"36","author":"Faria","year":"1992","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2016.09.001_bb0325","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1093\/humrep\/12.10.2123","article-title":"Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle","volume":"12","author":"Juul","year":"1997","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.ghir.2016.09.001_bb0330","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0378-5122(97)00088-1","article-title":"Alterations in the insulin-like growth factor system during the menstrual cycle in normal women","volume":"28","author":"Helle","year":"1998","journal-title":"Maturitas"},{"key":"10.1016\/j.ghir.2016.09.001_bb0335","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/jcem.83.5.4761","article-title":"Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women","volume":"83","author":"Ovesen","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0340","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S8756-3282(99)00076-9","article-title":"A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group","volume":"24","author":"Delmas","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.ghir.2016.09.001_bb0345","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s774-002-8446-8","article-title":"Comparison of the effects of transdermal estrogen, oral estrogen, and oral estrogen-progestogen therapy on bone mineral density in postmenopausal women","volume":"20","author":"Cetinkaya","year":"2002","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0350","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF01622195","article-title":"Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss","volume":"4","author":"Hillard","year":"1994","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ghir.2016.09.001_bb0355","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180285","article-title":"Effect of the variations of female sex hormones during the menstrual cycle upon serum somatomedin and growth-promoting activity","volume":"23","author":"Guidoux","year":"1986","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2016.09.001_bb0360","first-page":"284","article-title":"Modulation of immunoreactive somatomedin-C levels by sex steroids","volume":"112","author":"Caufriez","year":"1986","journal-title":"Acta Endocrinol."},{"key":"10.1016\/j.ghir.2016.09.001_bb0365","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000293276","article-title":"Altered growth hormone secretion during oral contraception","volume":"30","author":"Karlsson","year":"1990","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.ghir.2016.09.001_bb0370","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0010-7824(00)00176-1","article-title":"Effects of two oral contraceptives on plasma levels of insulin-like growth factor I (IGF-I) and growth hormone (hGH)","volume":"62","author":"Balogh","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.ghir.2016.09.001_bb0375","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2265.1993.tb02411.x","article-title":"Effect of oestrogen status on serum levels of growth hormone-binding protein and insulin-like growth factor-I in non-pregnant and pregnant women","volume":"39","author":"Massa","year":"1993","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2016.09.001_bb0380","first-page":"377","article-title":"Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women","volume":"10","author":"Jernstrom","year":"2001","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ghir.2016.09.001_bb0385","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000292493","article-title":"Suppression of plasma insulin-like growth factor-1 levels in healthy, nulliparous, young women using low dose oral contraceptives","volume":"38","author":"Jernstrom","year":"1994","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.ghir.2016.09.001_bb0390","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1472-6874-11-15","article-title":"A cross-sectional study of different patterns of oral contraceptive use among premenopausal women and circulating IGF-1: implications for disease risk","volume":"11","author":"Blackmore","year":"2011","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.ghir.2016.09.001_bb0395","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpag.2009.04.008","article-title":"Bone accretion in adolescents using the combined estrogen and progestin transdermal contraceptive method Ortho Evra: a pilot study","volume":"23","author":"Harel","year":"2010","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"10.1016\/j.ghir.2016.09.001_bb0400","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12020-014-0290-2","article-title":"The effect of oral contraceptive different patterns of use on circulating IGF-1 and bone mineral density in healthy premenopausal women","volume":"48","author":"Elkazaz","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.ghir.2016.09.001_bb0405","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1210\/jcem.87.6.8574","article-title":"Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa","volume":"87","author":"Grinspoon","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2016.09.001_bb0410","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1210\/jc.2011-0298","article-title":"Gender, sex-steroid, and secretagogue-selective recovery from growth hormone-induced feedback in older women and men","volume":"96","author":"Veldhuis","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637416300521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637416300521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:49:49Z","timestamp":1761086989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637416300521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":82,"alternative-id":["S1096637416300521"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2016.09.001","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A summary of the influence of exogenous estrogen administration across the lifespan on the GH\/IGF-1 axis and implications for bone health","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2016.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}